Cantor’s Neurology & Psychiatry Conference featured interactive discussions, one-on-ones, and panel presentations, focused on Neuro-Innovators that develop and commercialize medicines for high unmet need indications in the Neurology & Psychiatry industries. The discussions delved into a range of topics, including: 

• ALS Treatment
• Next Generation Drugs
• Psychedelic-supported Treatment
• Neuro/Psych Clinical Trials
• Digital Therapeutics (DTx)